Biodyne바이오다인
314930 · KOSDAQ · ₩314930 · 바이오다인
₩5,890▲ ₩120 (2.08%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 61.0% | 63.6% | 46.2% | 16.7% | 76.2% | 13.2% |
| Operating margin | 1.3% | 9.3% | −32.8% | −50.2% | 54.7% | −62.2% |
| Net margin | 13.6% | 12.1% | 0.2% | −24.3% | 46.0% | −288.5% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −17.8% | +33.3% | +28.9% | −66.5% | +224.5% | — |
| Operating income growth | −88.2% | +137.7% | +15.7% | −130.7% | +385.3% | — |
| Net income growth | −7.5% | +7,807.0% | +101.1% | −117.7% | +151.7% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 1.8% | 2.0% | 0.0% | −2.3% | 13.6% | −28.2% |
| Return on assets | 1.4% | 1.9% | 0.0% | −2.2% | 12.3% | −23.7% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 0.9% | 2.0% | 2.7% | 1.4% | 2.8% | 19.0% |
| Net debt to equity | −33.5% | — | −47.9% | −45.5% | −24.3% | −24.6% |
| Current ratio | 4,594.7% | 2,147.8% | 1,948.4% | 3,499.6% | 1,827.9% | 382.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Biodyne / 바이오다인 / 314930 / KRX:314930
Source: KRX statistical information